The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ACACIA COMMUNICATIONS INC | COM | 00401C108 | 42,463 | 626,202 | SH | SOLE | 626,202 | 0 | 0 | ||
CAESARS ENTMT CORP | COM | 127686103 | 418,886 | 30,800,442 | SH | SOLE | 30,800,442 | 0 | 0 | ||
MEDICINES CO | COM | 584688105 | 329,567 | 3,880,000 | SH | SOLE | 3,880,000 | 0 | 0 | ||
RA PHARMACEUTICALS INC | COM | 74933V108 | 3,818 | 81,365 | SH | SOLE | 81,365 | 0 | 0 | ||
TD AMERITRADE HLDG CORP | COM | 87236Y108 | 99,410 | 2,000,200 | SH | SOLE | 2,000,200 | 0 | 0 | ||
TIFFANY & CO NEW | COM | 886547108 | 80,649 | 603,432 | SH | SOLE | 603,432 | 0 | 0 |